TY - JOUR
T1 - Importance of external validation and subgroup analysis of artificial intelligence in the detection of low ejection fraction from electrocardiograms
AU - Yagi, Ryuichiro
AU - Goto, Shinichi
AU - Katsumata, Yoshinori
AU - Macrae, Calum A.
AU - Deo, Rahul C.
N1 - Funding Information:
Conflict of interest: R.C.D. is supported by grants from the National Institute of Health, the American Heart Association (One Brave Idea, Apple Heart, and Movement Study), has received consulting fees from Novartis and Pfizer, and is co-founder of Atman Health. C.A.M. is a consultant for Pfizer and co-founder of Atman Health. S.G. is partially supported by Drs Morton and Toby Mower Science Innovation Fund Fellowship, a grant from The Japanese Society of Thrombosis and Hemostasis and One Brave Idea.
Publisher Copyright:
© 2022 The Author(s). Published by Oxford University Press on behalf of the European Society of Cardiology.
PY - 2022/12/1
Y1 - 2022/12/1
N2 - Aim: Left ventricular systolic dysfunction (LVSD) carries an increased risk for overt heart failure and mortality, yet treatable to mitigate disease progression. An artificial intelligence (AI)-enabled 12-lead electrocardiogram (ECG) model demonstrated promise in LVSD screening, but the performance dropped unexpectedly in external validation. We thus sought to train de novo models for LVSD detection and investigated their performance across multiple institutions and across a broader set of patient strata. Methods and results: ECGs taken within 14 days of an echocardiogram were obtained from four academic hospitals (three in the United States and one in Japan). Four AI models were trained to detect patients with ejection fraction (EF) <40% using ECGs from each of the four institutions. All the models were then evaluated on the held-out test data set from the same institution and data from the three external institutions. Subgroup analyses stratified by patient characteristics and common ECG abnormalities were performed. A total of 221 846 ECGs were identified from the 4 institutions. While the Brigham and Women's Hospital (BWH)-trained and Keio-trained models yielded similar accuracy on their internal test data [area under the receiver operating curve (AUROC) 0.913 and 0.914, respectively], external validity was worse for the Keio-trained model (AUROC: 0.905-0.915 for BWH trained and 0.849-0.877 for Keio-trained model). Although ECG abnormalities including atrial fibrillation, left bundle branch block, and paced rhythm-reduced detection, the models performed robustly across patient characteristics and other ECG features. Conclusion: While using the same model architecture, different data sets produced models with different performances for detecting low-EF highlighting the importance of external validation and extensive stratification analysis.
AB - Aim: Left ventricular systolic dysfunction (LVSD) carries an increased risk for overt heart failure and mortality, yet treatable to mitigate disease progression. An artificial intelligence (AI)-enabled 12-lead electrocardiogram (ECG) model demonstrated promise in LVSD screening, but the performance dropped unexpectedly in external validation. We thus sought to train de novo models for LVSD detection and investigated their performance across multiple institutions and across a broader set of patient strata. Methods and results: ECGs taken within 14 days of an echocardiogram were obtained from four academic hospitals (three in the United States and one in Japan). Four AI models were trained to detect patients with ejection fraction (EF) <40% using ECGs from each of the four institutions. All the models were then evaluated on the held-out test data set from the same institution and data from the three external institutions. Subgroup analyses stratified by patient characteristics and common ECG abnormalities were performed. A total of 221 846 ECGs were identified from the 4 institutions. While the Brigham and Women's Hospital (BWH)-trained and Keio-trained models yielded similar accuracy on their internal test data [area under the receiver operating curve (AUROC) 0.913 and 0.914, respectively], external validity was worse for the Keio-trained model (AUROC: 0.905-0.915 for BWH trained and 0.849-0.877 for Keio-trained model). Although ECG abnormalities including atrial fibrillation, left bundle branch block, and paced rhythm-reduced detection, the models performed robustly across patient characteristics and other ECG features. Conclusion: While using the same model architecture, different data sets produced models with different performances for detecting low-EF highlighting the importance of external validation and extensive stratification analysis.
KW - Ejection fraction
KW - Electrocardiogram
KW - External validation
KW - Neural network
UR - http://www.scopus.com/inward/record.url?scp=85148722762&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85148722762&partnerID=8YFLogxK
U2 - 10.1093/ehjdh/ztac065
DO - 10.1093/ehjdh/ztac065
M3 - Article
AN - SCOPUS:85148722762
SN - 2634-3916
VL - 3
SP - 654
EP - 657
JO - European Heart Journal - Digital Health
JF - European Heart Journal - Digital Health
IS - 4
ER -